Hfm Investment Advisors, LLC Biotechnology

Hfm Investment Advisors, LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
UTHR United Therapeutics Corp	$13.2B	$617,000 0.0% of portfolio	2	Q1 2025 New
VRTX Vertex Pharmaceuticals Inc	$116B	$485,000 0.0% of portfolio	1	Q1 2025 New
EXEL Exelixis, Inc.	$14B	$296,000 0.0% of portfolio	8	Q1 2025 New
ALNY Alnylam Pharmaceuticals, Inc.	$39.6B	$271,000 0.0% of portfolio	1	Q1 2025 New
JAZZ Jazz Pharmaceuticals PLC	$6.86B	$249,000 0.0% of portfolio	2	Q1 2025 New
CORT Corcept Therapeutics Inc	$7.42B	$229,000 0.0% of portfolio	2	Q1 2025 New
BMRN Biomarin Pharmaceutical Inc	$10.4B	$213,000 0.0% of portfolio	3	Q1 2025 New
HALO Halozyme Therapeutics, Inc.	$7.37B	$192,000 0.0% of portfolio	3	Q1 2025 New
INCY Incyte Corp	$15.3B	$182,000 0.0% of portfolio	3	Q1 2025 New
TECH Bio Techne Corp	$2.04B	$118,000 0.0% of portfolio	2	Q1 2025 New
BBIO Bridge Bio Pharma, Inc.	$6.34B	$104,000 0.0% of portfolio	3	Q1 2025 New
PTCT Ptc Therapeutics, Inc.	$3.48B	$102,000 0.0% of portfolio	2	Q1 2025 New
ADMA Adma Biologics, Inc.	$3.56B	$60,000 0.0% of portfolio	3	Q1 2025 New
HRMY Harmony Biosciences Holdings, Inc.	$1.89B	$34,000 0.0% of portfolio	1	Q1 2025 New
AGIO Agios Pharmaceuticals, Inc.	$1.88B	$30,000 0.0% of portfolio	1	Q1 2025 New
VCYT Veracyte, Inc.	$1.96B	$30,000 0.0% of portfolio	1	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.23B	$20,000 0.0% of portfolio	1	Q1 2025 New
SMMT Summit Therapeutics Inc.	$4.29B	$20,000 0.0% of portfolio	1	Q1 2025 New
IBRX Immunity Bio, Inc.	$1.03B	$19,000 0.0% of portfolio	6	Q1 2025 New

Get notified when there are updates to the investment portfolio of Hfm Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hfm Investment Advisors, LLC with notifications on news.